beta-lactams has been researched along with Koch's Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (4.00) | 29.6817 |
| 2010's | 14 (56.00) | 24.3611 |
| 2020's | 10 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Das, R; Mehta, DK | 1 |
| Anes, E; Catalão, MJ; Gomes, JP; Macedo, R; Miragaia, M; Nunes, A; Olivença, F; Pires, D; Silveiro, C | 1 |
| Aldrich, CC; Baughn, AD; Brody, SI; Buonomo, JA; Cole, MS; Howe, MD; Lamont, EA; Minato, Y; Mishra, NK; Sharma, S; Thiede, JM | 1 |
| Cui, J; Feng, L; Han, X; He, S; James, TD; Ma, X; Tian, X; Wang, C; Wang, J; Yan, F | 1 |
| Fontaine, E; Roubert, C; Upton, AM | 1 |
| Andrés Libreros-Zúñiga, G; Cristina de Moraes Roso Mesquita, N; de Morais Barroso, V; Fehelberg Pinto Braga, S; Ishida, K; Oliva, G; Pavão E Pavão, D; Salgado Ferreira, R; Vinicius Bertacine Dias, M | 1 |
| Guddat, L; Liu, X; Lu, Z; Rao, Z; Schofield, CJ; Wang, H; Yang, C; Yang, H; Zhang, A; Zhou, W | 1 |
| Beatty, KE | 1 |
| Bozdogan, B; Coban, AY; Gun, MA | 1 |
| Drobniewski, F; Gonzalo, X; McHugh, TD; Ortiz Canseco, J; Satta, G | 1 |
| Raghunand, TR; Viswanathan, G; Yadav, S | 1 |
| Lamichhane, G; Story-Roller, E | 1 |
| Bates, RH; Epemolu, O; Martinez-Martinez, MS; Peet, C; Read, KD; Smith, PW; Zuccotto, F | 1 |
| Sharma, AK; Vats, P | 1 |
| Ato, M; Fukuda, T; Hamasaki, M; Kinoshita, T; Kobayashi, K; Maeda, Y; Matsumoto, S; Matsumura, T; Morita, YS; Murakami, Y; Nishiuchi, Y; Yoshimori, T | 1 |
| Bush, K; Pucci, MJ | 1 |
| Bishai, WR; Lamichhane, G; Schoonmaker, MK | 1 |
| Angulo-Barturen, I; Arthur, M; Ballell, L; Barros-Aguirre, D; Dhar, N; Diacon, AH; García-Pérez, A; Hugonnet, JE; Lelievre, J; McKinney, JD; Rullas, J | 1 |
| Anderson, WF; Filippova, EV; Kieser, KJ; Kiryukhina, O; Luan, CH; Rubin, EJ; Wawrzak, Z | 1 |
| Gomez, JE; Hung, DT; Wellington, S; Wivagg, CN | 1 |
| Deshpande, D; Gumbo, T; Nuermberger, E; Pasipanodya, JG; Srivastava, S; Swaminathan, S | 1 |
| Schneider, G; Schnell, R; Steiner, EM | 1 |
| Chen, TL; Fung, CP; Huang, LJ; Jeng, YY; Lin, YT; Liu, CY; Wang, FD | 1 |
| Schlitzer, M; Weeken, D | 1 |
| Boshoff, H; Brodin, P; Cole, ST; Demangel, C; Jackson, M; Marsollier, L; Saint-Joanis, B | 1 |
5 review(s) available for beta-lactams and Koch's Disease
| Article | Year |
|---|---|
Fluorescent probes for investigating peptidoglycan biosynthesis in mycobacteria.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Biosynthetic Pathways; Fluorescent Dyes; Humans; Models, Molecular; Mycobacterium tuberculosis; Optical Imaging; Peptides; Peptidoglycan; Peptidyl Transferases; Tuberculosis; Vancomycin | 2020 |
Tuberculosis and beta-lactam antibiotics.
Topics: Animals; Anti-Bacterial Agents; Antitubercular Agents; beta-Lactamases; beta-Lactams; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
Have we realized the full potential of β-lactams for treating drug-resistant TB?
Topics: Animals; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Humans; Mycobacterium tuberculosis; Tuberculosis | 2018 |
Investigational antimicrobial agents of 2013.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Bacterial Proteins; beta-Lactamase Inhibitors; beta-Lactams; Clinical Trials as Topic; Clostridium Infections; Drug Combinations; Drug Resistance, Multiple, Bacterial; Drugs, Investigational; Gram-Negative Bacteria; Gram-Positive Bacteria; Health Surveys; Humans; Molecular Mimicry; Protein Synthesis Inhibitors; Topoisomerase Inhibitors; Tuberculosis | 2013 |
[Accidental discoveries, different mechanisms of action. Active agents against Mycobacterium tuberculosis in clinical application].
Topics: Antitubercular Agents; beta-Lactams; Drug Discovery; Fatty Acid Synthases; Humans; Mycobacterium tuberculosis; Protein Synthesis Inhibitors; Topoisomerase II Inhibitors; Tuberculosis | 2012 |
20 other study(ies) available for beta-lactams and Koch's Disease
| Article | Year |
|---|---|
Evaluation and Docking Study of Pyrazine Containing 1, 3, 4-Oxadiazoles Clubbed with Substituted Azetidin-2-one: A New Class of Potential Antimicrobial and Antitubercular.
Topics: Antifungal Agents; Antitubercular Agents; Aspergillus niger; Azetidines; Candida albicans; Drug Evaluation, Preclinical; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Mycobacterium tuberculosis; Mycoses; Oxadiazoles; Pyrazinamide; Tuberculosis | 2021 |
Uncovering Beta-Lactam Susceptibility Patterns in Clinical Isolates of Mycobacterium tuberculosis through Whole-Genome Sequencing.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Peptidoglycan; Tuberculosis | 2022 |
Cephem-Pyrazinoic Acid Conjugates: Circumventing Resistance in Mycobacterium tuberculosis.
Topics: Antitubercular Agents; beta-Lactams; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Pyrazinamide; Tuberculosis | 2022 |
High-throughput fluorescent screening of β-lactamase inhibitors to improve antibiotic treatment strategies for tuberculosis.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Biosensing Techniques; Fluorescent Dyes; High-Throughput Screening Assays; Humans; Mycobacterium tuberculosis; Tannins; Tuberculosis | 2022 |
"Upcycling" known molecules and targets for drug-resistant TB.
Topics: Antitubercular Agents; beta-Lactams; Ethionamide; Humans; Spectinomycin; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2022 |
Integration of biophysical and biological approaches to validate fragment-like compounds targeting l,d-transpeptidases from Mycobacterium tuberculosis.
Topics: Anti-Bacterial Agents; Antitubercular Agents; beta-Lactams; Humans; Mycobacterium tuberculosis; Peptidyl Transferases; Tuberculosis | 2024 |
Structures of
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactams; Crystallography, X-Ray; Drug Design; Meropenem; Microbial Sensitivity Tests; Models, Molecular; Mycobacterium tuberculosis; Penicillin-Binding Proteins; Protein Binding; Protein Domains; Recombinant Proteins; Tuberculosis | 2020 |
Ertapenem and Faropenem against Mycobacterium tuberculosis: in vitro testing and comparison by macro and microdilution.
Topics: Amoxicillin-Potassium Clavulanate Combination; Antitubercular Agents; beta-Lactams; Drug Resistance, Bacterial; Ertapenem; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2020 |
Identification of Mycobacterial Genes Involved in Antibiotic Sensitivity: Implications for the Treatment of Tuberculosis with β-Lactam-Containing Regimens.
Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Clavulanic Acid; Dibenzothiepins; Drug Resistance, Microbial; Meropenem; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Thienamycins; Tuberculosis | 2017 |
Pharmacokinetics of β-Lactam Antibiotics: Clues from the Past To Help Discover Long-Acting Oral Drugs in the Future.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; beta-Lactams; Biological Availability; Cell Membrane Permeability; Drug Discovery; Half-Life; Haplorhini; Humans; Mycobacterium tuberculosis; Protein Binding; Retrospective Studies; Solubility; Treatment Outcome; Tuberculosis | 2018 |
Evaluation of biochemical and molecular polymorphism in extended spectrum β-lactamases of Mycobacterium tuberculosis clinical isolates.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Blotting, Southern; Cefotaxime; Cephalosporins; Clavulanic Acid; Humans; Isoelectric Focusing; Kinetics; Mycobacterium tuberculosis; Polymerase Chain Reaction; Tuberculosis | 2019 |
Critical roles for lipomannan and lipoarabinomannan in cell wall integrity of mycobacteria and pathogenesis of tuberculosis.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Cell Wall; Female; Lipopolysaccharides; Macrophages; Mice; Mice, Inbred C57BL; Microbial Viability; Mycobacterium smegmatis; Mycobacterium tuberculosis; Tuberculosis | 2013 |
Nonclassical transpeptidases of Mycobacterium tuberculosis alter cell size, morphology, the cytosolic matrix, protein localization, virulence, and resistance to β-lactams.
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactams; Cytosol; Female; Humans; Mice, Inbred BALB C; Mycobacterium tuberculosis; Peptidyl Transferases; Protein Transport; Tuberculosis; Virulence | 2014 |
Combinations of β-Lactam Antibiotics Currently in Clinical Trials Are Efficacious in a DHP-I-Deficient Mouse Model of Tuberculosis Infection.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Dipeptidases; Disease Models, Animal; Drug Therapy, Combination; GPI-Linked Proteins; Lung; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Respiratory Tract Infections; Staphylococcal Infections; Tuberculosis | 2015 |
Crystal structures of the transpeptidase domain of the Mycobacterium tuberculosis penicillin-binding protein PonA1 reveal potential mechanisms of antibiotic resistance.
Topics: beta-Lactams; Binding Sites; Crystallography, X-Ray; Drug Resistance, Microbial; Humans; Mutagenesis, Site-Directed; Mycobacterium tuberculosis; Penicillin V; Penicillin-Binding Proteins; Peptidyl Transferases; Tuberculosis | 2016 |
Loss of a Class A Penicillin-Binding Protein Alters β-Lactam Susceptibilities in Mycobacterium tuberculosis.
Topics: beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactams; Gene Expression Regulation, Bacterial; Mutagenesis, Insertional; Mycobacterium tuberculosis; Penicillin-Binding Proteins; Structure-Activity Relationship; Tuberculosis | 2016 |
A Faropenem, Linezolid, and Moxifloxacin Regimen for Both Drug-Susceptible and Multidrug-Resistant Tuberculosis in Children: FLAME Path on the Milky Way.
Topics: Antitubercular Agents; Bacterial Load; beta-Lactams; Child; Computer Simulation; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoroquinolones; Humans; Linezolid; Microbial Sensitivity Tests; Models, Theoretical; Moxifloxacin; Mycobacterium tuberculosis; Tuberculosis; Tuberculosis, Multidrug-Resistant | 2016 |
Binding and processing of β-lactam antibiotics by the transpeptidase Ldt
Topics: beta-Lactams; Carbapenems; Crystallography, X-Ray; Kinetics; Mycobacterium tuberculosis; Peptidoglycan; Peptidyl Transferases; Protein Conformation; Tuberculosis | 2017 |
Does radiographic evidence of prior pulmonary tubercular infection influence the choice of empiric antibiotics for community-acquired pneumonia in a tuberculosis-endemic area?
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Clinical Protocols; Community-Acquired Infections; Comorbidity; Endemic Diseases; Fluoroquinolones; Humans; Middle Aged; Pneumonia; Radiography; Retrospective Studies; Treatment Outcome; Tuberculosis | 2010 |
Inactivation of Rv2525c, a substrate of the twin arginine translocation (Tat) system of Mycobacterium tuberculosis, increases beta-lactam susceptibility and virulence.
Topics: Amino Acid Sequence; Animals; Antitubercular Agents; Bacterial Proteins; beta-Lactams; Cells, Cultured; Colony Count, Microbial; Female; Gene Deletion; Gene Order; Genes, Bacterial; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Molecular Sequence Data; Mycobacterium tuberculosis; Protein Transport; Sequence Alignment; Spleen; Survival Analysis; Tuberculosis; Virulence | 2006 |